© 2021 BioMarin. All rights reserved.

BioMarin to Participate in Citi's 13th Annual Biotech Conference on December 5 in New York City
Dec 3, 2018

SAN RAFAEL, Calif., Dec. 3, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that management will participate in Citi's 13th Annual Biotech Conference on December 5 in New York City.  To access the live webcast, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.

BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.




Traci McCarty                                     

Debra Charlesworth

BioMarin Pharmaceutical Inc.              

BioMarin Pharmaceutical Inc.

(415) 455-7558                                     

(415) 455-7451


SOURCE BioMarin Pharmaceutical Inc.